EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Cephalosporins Versus Non-cephalosporin Antibiotics for Perioperative Prophylaxis in Primary Arthroplasty: A Systematic Review and Meta-Analysis

Rita Igwilo-Alaneme iD, Elie Berbari, Jack McHugh iD, Francesco Petri iD, Vasupriya Ravi, Takahiro Matsuo iD, Fabio Borgonovo iD, Said El Zein iD, M Hassan Murad, Aaron Tande iD

Clinical Infectious Diseases · 20.05.2026 · 82 (5) · 888-900

DOI: 10.1093/cid/ciag172 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Clinical Infectious Diseases, online erschienen am 14.03.2026. Verfasst von Rita Igwilo-Alaneme und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Antibiotic Prophylaxis, Anti-Bacterial Agents, Cephalosporins, Surgical Wound Infection. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: NCATS NIH HHS, NIH, CTSA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The number of arthroplasty procedures and infection-related complications, including prosthetic joint infections (PJIs) and surgical site infections (SSIs), continues to rise. Although current guidelines recommend cefazolin or cefuroxime as the first-line perioperative prophylactic antibiotic, substitutions with non-cephalosporins remain common, especially among patients with reported β-lactam allergies. These substitutions may increase infection risk and healthcare costs. Evidence comparing outcomes across antibiotic classes remains variable.

Methods

We conducted a systematic review and meta-analysis of studies comparing single-agent cephalosporin versus single-agent non-cephalosporin prophylaxis in adults undergoing primary arthroplasty. Cochrane, Embase, Medline, Scopus, and Web of Science were searched from database inception through January 2025. Random-effect or fixed-effect models were used to estimate pooled odds ratios (OR) and 95% confidence intervals (CI). Subgroup analyses stratified results by cephalosporin type, study era, and risk of bias.

Results

Twenty-three studies (7 randomized controlled trials and 16 observational studies) were included, encompassing 191 527 arthroplasties in the cephalosporin arm and 20 058 in the non-cephalosporin arm. The odds of PJI were lower with cephalosporins (OR 0.59; 95% CI, .46–.75). No overall difference was observed for SSI (OR 0.70; 95% CI, .36–1.36), though post-2013 studies and the cefazolin subgroup demonstrated a significant protective effect. Randomized trial estimates were limited and heterogeneous and did not reach statistical significance. Certainty of evidence was graded as moderate.

Conclusions

Cephalosporins, particularly cefazolin or cefuroxime, remain the preferred prophylactic agents for primary arthroplasty. This quantitative synthesis reinforces their protective association against prosthetic joint infection and supports adherence to guideline-endorsed prophylaxis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibiotic ProphylaxisAnti-Bacterial AgentsCephalosporinsSurgical Wound InfectionArthroplastyProsthesis-Related InfectionsHumansCefazolinFirst Generation CephalosporinsSecond Generation CephalosporinsCefuroxime

Stichwörter der Autor:innen

arthroplastycephalosporinsperioperative antimicrobial prophylaxisprosthetic joint infectionsurgical site infection

Substanzen

Anti-Bacterial AgentsCephalosporinsCefazolinFirst Generation CephalosporinsSecond Generation CephalosporinsCefuroxime

Autor:innen und Institutionen

  • Division of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Infectious Disease, ASST FBF SACCO Fatebenefratelli, Milano, Lombardia, Italy.
  • Division of Plastic Surgery, Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Rita Igwilo-Alaneme, Jack McHugh, Francesco Petri, Takahiro Matsuo, Fabio Borgonovo, Said El Zein, Aaron Tande

Förderung

  • NCATS NIH HHS
  • NIH
  • CTSA

Zitieren

APA

Igwilo-Alaneme, R., Berbari, E., McHugh, J., Petri, F., Ravi, V., Matsuo, T., Borgonovo, F., El Zein, S., Murad, M. H., & Tande, A. (2026). Cephalosporins Versus Non-cephalosporin Antibiotics for Perioperative Prophylaxis in Primary Arthroplasty: A Systematic Review and Meta-Analysis. Clinical Infectious Diseases, 82(5), 888-900. https://doi.org/10.1093/cid/ciag172

Vancouver

Igwilo-Alaneme R, Berbari E, McHugh J, Petri F, Ravi V, Matsuo T, et al. Cephalosporins Versus Non-cephalosporin Antibiotics for Perioperative Prophylaxis in Primary Arthroplasty: A Systematic Review and Meta-Analysis. Clinical Infectious Diseases. 2026;82(5):888-900. doi:10.1093/cid/ciag172

BibTeX
@article{IgwiloAlaneme2026,
  author = {Igwilo-Alaneme, Rita and Berbari, Elie and McHugh, Jack and Petri, Francesco and Ravi, Vasupriya and Matsuo, Takahiro and Borgonovo, Fabio and El Zein, Said and Murad, M Hassan and Tande, Aaron},
  title = {Cephalosporins Versus Non-cephalosporin Antibiotics for Perioperative Prophylaxis in Primary Arthroplasty: A Systematic Review and Meta-Analysis},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  volume = {82},
  number = {5},
  pages = {888--900},
  doi = {10.1093/cid/ciag172}
}
Kostenlos starten →